NYSE · CIK 0001596967
MC Moelis & Co
Insider trading from SEC Form 4. Last filing 20 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Signals
Open-market buys and sells at Moelis & Co, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 38Weak | sell 2 | Christopher Callesano Principal Accounting Officer | $95k | 1,282 | -51% | - | |
| 38Weak | sell 2 | Eric Cantor Vice Chairman, MD | $1.2M | 16,530 | -7% | - | |
| 43Moderate | sell | Christopher Callesano Principal Accounting Officer | $71k | 885 | -100% | - |
Transactions
The last 86 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Thorold Barker director | AGrant or award 2025 Annual Restricted Stock Units | +18 | - | - | 1,683 | 20 d ago |
| Sep 17, 2026 | Christopher Callesano Chief Financial Officer | AGrant or award 2021 Incentive RSUsderivative | +4 | $0.00 | $0 | 396 | 20 d ago |
| Sep 17, 2026 | Eric Cantor Vice Chairman, MD | AGrant or award 2021 Incentive RSUsderivative | +78 | $0.00 | $0 | 7,203 | 20 d ago |
| Sep 17, 2026 | Thorold Barker director | AGrant or award 2026 Annual Restricted Stock Units | +17 | - | - | 1,562 | 20 d ago |
| Sep 17, 2026 | Eric Cantor Vice Chairman, MD | AGrant or award 2022 Incentive RSUsderivative | +195 | $0.00 | $0 | 18,068 | 20 d ago |
| Sep 17, 2026 | Christopher Callesano Chief Financial Officer | AGrant or award 2022 Incentive RSUsderivative | +14 | $0.00 | $0 | 1,249 | 20 d ago |
| Sep 17, 2026 | Christopher Callesano Chief Financial Officer | AGrant or award 2023 Incentive RSUsderivative | +14 | $0.00 | $0 | 1,288 | 20 d ago |
| Sep 17, 2026 | Eric Cantor Vice Chairman, MD | AGrant or award 2023 Incentive RSUsderivative | +225 | $0.00 | $0 | 20,849 | 20 d ago |
| Sep 17, 2026 | Eric Cantor Vice Chairman, MD | AGrant or award 2024 Incentive RSUsderivative | +142 | $0.00 | $0 | 13,162 | 20 d ago |
| Sep 17, 2026 | Christopher Callesano Chief Financial Officer | AGrant or award 2024 Incentive RSUsderivative | +15 | $0.00 | $0 | 1,371 | 20 d ago |
| Sep 17, 2026 | Eric Cantor Vice Chairman, MD | AGrant or award 2024 Long Term Incentive RSUsderivative | +74 | $0.00 | $0 | 6,854 | 20 d ago |
| Mar 27, 2025 | Eric Cantor Vice Chairman, MD | AGrant or award 2020 Incentive RSUsderivative | +77 | $0.00 | $0 | 7,182 | Mar 31, 2025 |
| Mar 27, 2025 | Christopher Callesano Chief Financial Officer | AGrant or award 2020 Incentive RSUsderivative | +5 | $0.00 | $0 | 431 | Mar 31, 2025 |
| Mar 27, 2025 | Christopher Callesano Chief Financial Officer | AGrant or award 2021 Incentive RSUsderivative | +8 | $0.00 | $0 | 745 | Mar 31, 2025 |
| Mar 27, 2025 | Eric Cantor Vice Chairman, MD | AGrant or award 2021 Incentive RSUsderivative | +146 | $0.00 | $0 | 13,545 | Mar 31, 2025 |
| Mar 27, 2025 | Christopher Callesano Chief Financial Officer | AGrant or award 2022 Incentive RSUsderivative | +19 | $0.00 | $0 | 1,762 | Mar 31, 2025 |
| Mar 27, 2025 | Eric Cantor Vice Chairman, MD | AGrant or award 2022 Incentive RSUsderivative | +275 | $0.00 | $0 | 25,482 | Mar 31, 2025 |
| Mar 27, 2025 | Christopher Callesano Chief Financial Officer | AGrant or award 2023 Incentive RSUsderivative | +17 | $0.00 | $0 | 1,614 | Mar 31, 2025 |
| Mar 27, 2025 | Eric Cantor Vice Chairman, MD | AGrant or award 2023 Incentive RSUsderivative | +282 | $0.00 | $0 | 26,137 | Mar 31, 2025 |
| Mar 27, 2025 | Christopher Callesano Chief Financial Officer | AGrant or award 2024 Incentive RSUsderivative | +17 | $0.00 | $0 | 1,610 | Mar 31, 2025 |
| Mar 27, 2025 | Eric Cantor Vice Chairman, MD | AGrant or award 2024 Incentive RSUsderivative | +167 | $0.00 | $0 | 15,469 | Mar 31, 2025 |
| Mar 27, 2025 | Eric Cantor Vice Chairman, MD | AGrant or award 2024 Long Term Incentive RSUsderivative | +69 | $0.00 | $0 | 6,444 | Mar 31, 2025 |
| Feb 19, 2025 | Christopher Callesano Principal Accounting Officer | MOption exercise Class A Common Stock | +2,511 | - | - | 2,511 | Feb 21, 2025 |
| Feb 19, 2025 | Eric Cantor Vice Chairman, MD | MOption exercise Class A Common Stock | +37,613 | - | - | 235,337 | Feb 21, 2025 |
| Feb 19, 2025 | Christopher Callesano Principal Accounting Officer | FTax withholding Class A Common Stock | -2 | $74.00 | $184 | 2,509 | Feb 21, 2025 |
| Feb 19, 2025 | Eric Cantor Vice Chairman, MD | FTax withholding Class A Common Stock | -2 | $74.00 | $111 | 235,335 | Feb 21, 2025 |
| Feb 19, 2025 | Christopher Callesano Principal Accounting Officer | SOpen-market sale Class A Common Stock | -1,282 | $74.00 | $95k | 1,227 | Feb 21, 2025 |
| Feb 19, 2025 | Eric Cantor Vice Chairman, MD | SOpen-market sale Class A Common Stock | -16,530 | $74.00 | $1.2M | 218,805 | Feb 21, 2025 |
| Feb 19, 2025 | Christopher Callesano Principal Accounting Officer | MOption exercise 2019 Incentive Restricted Stock Unitsderivative | -736 | $0.00 | $0 | 0 | Feb 21, 2025 |
| Feb 19, 2025 | Eric Cantor Vice Chairman, MD | MOption exercise 2019 Incentive Restricted Stock Unitsderivative | -10,300 | $0.00 | $0 | 0 | Feb 21, 2025 |
| Feb 19, 2025 | Christopher Callesano Principal Accounting Officer | MOption exercise 2020 Incentive Restricted Stock Unitsderivative | -426 | $0.00 | $0 | 426 | Feb 21, 2025 |
| Feb 19, 2025 | Eric Cantor Vice Chairman, MD | MOption exercise 2020 Incentive Restricted Stock Unitsderivative | -7,105 | $0.00 | $0 | 7,105 | Feb 21, 2025 |
| Feb 19, 2025 | Christopher Callesano Principal Accounting Officer | MOption exercise 2021 Incentive Restricted Stock Unitsderivative | -369 | $0.00 | $0 | 737 | Feb 21, 2025 |
| Feb 19, 2025 | Eric Cantor Vice Chairman, MD | MOption exercise 2021 Incentive Restricted Stock Unitsderivative | -6,700 | $0.00 | $0 | 13,399 | Feb 21, 2025 |
| Feb 19, 2025 | Christopher Callesano Principal Accounting Officer | MOption exercise 2022 Incentive Restricted Stock Unitsderivative | -581 | $0.00 | $0 | 1,743 | Feb 21, 2025 |
| Feb 19, 2025 | Eric Cantor Vice Chairman, MD | MOption exercise 2022 Incentive Restricted Stock Unitsderivative | -8,401 | $0.00 | $0 | 25,207 | Feb 21, 2025 |
| Feb 19, 2025 | Christopher Callesano Principal Accounting Officer | MOption exercise 2023 Incentive Restricted Stock Unitsderivative | -399 | $0.00 | $0 | 1,597 | Feb 21, 2025 |
| Feb 19, 2025 | Eric Cantor Vice Chairman, MD | MOption exercise 2023 Incentive Restricted Stock Unitsderivative | -5,107 | $0.00 | $0 | 25,855 | Feb 21, 2025 |
| Feb 13, 2025 | Christopher Callesano Principal Accounting Officer | AGrant or award 2024 Incentive RSUsderivative | +1,593 | $0.00 | $0 | 1,593 | Feb 14, 2025 |
| Feb 13, 2025 | Eric Cantor Vice Chairman, MD | AGrant or award 2024 Vested Incentive RSUsderivative | +15,302 | $0.00 | $0 | 15,302 | Feb 14, 2025 |
| Feb 13, 2025 | Eric Cantor Vice Chairman, MD | AGrant or award 2024 Long Term Incentive RSUsderivative | +6,375 | $0.00 | $0 | 6,375 | Feb 14, 2025 |
| Feb 6, 2025 | Eric Cantor Vice Chairman, MD | MOption exercise Class A Common Stock | +876 | - | - | 198,109 | Feb 6, 2025 |
| Feb 6, 2025 | Eric Cantor Vice Chairman, MD | FTax withholding Class A Common Stock | -385 | $79.68 | $31k | 197,724 | Feb 6, 2025 |
| Feb 6, 2025 | Eric Cantor Vice Chairman, MD | MOption exercise 2019 Incentive RSUs (December)derivative | -876 | $0.00 | $0 | 0 | Feb 6, 2025 |
| Dec 3, 2024 | Eric Cantor Vice Chairman, MD | MOption exercise Class A Common Stock | +1,356 | - | - | 198,589 | Dec 4, 2024 |
| Dec 2, 2024 | Navid Mahmoodzadegan Co-President, MD | AGrant or award 2019 Incentive RSUsderivative | +448 | $0.00 | $0 | 57,009 | Dec 4, 2024 |
| Dec 2, 2024 | Kenneth Moelis Chairman, CEO | AGrant or award 2019 Long Term Incentive Awardderivative | +462 | $0.00 | $0 | 58,861 | Dec 4, 2024 |
| Dec 2, 2024 | Louise Mirrer director | AGrant or award 2024 Annual Restricted Stock Units | +10 | - | - | 1,216 | Dec 4, 2024 |
| Dec 2, 2024 | Laila Worrell director | AGrant or award 2023 Annual Restricted Stock Units | +20 | - | - | 2,484 | Dec 4, 2024 |
| Dec 2, 2024 | Kenneth Shropshire director | AGrant or award 2023 Annual Restricted Stock Units | +20 | - | - | 2,603 | Dec 4, 2024 |
| Dec 2, 2024 | Osamu R. Watanabe General Counsel, Secretary | AGrant or award 2019 Incentive RSUsderivative | +35 | $0.00 | $0 | 4,413 | Dec 4, 2024 |
| Dec 2, 2024 | Joseph Simon Chief Financial Officer | AGrant or award 2019 Incentive RSUsderivative | +59 | $0.00 | $0 | 7,467 | Dec 4, 2024 |
| Dec 2, 2024 | Christopher Callesano Principal Accounting Officer | AGrant or award 2019 Incentive RSUsderivative | +6 | $0.00 | $0 | 736 | Dec 4, 2024 |
| Dec 2, 2024 | Jeffrey Raich Co-President, MD | AGrant or award 2019 Incentive RSUsderivative | +147 | $0.00 | $0 | 18,758 | Dec 4, 2024 |
| Dec 2, 2024 | Ciafone Katherine Pilcher Chief Operating Officer | AGrant or award 2019 Incentive RSUsderivative | +22 | $0.00 | $0 | 2,759 | Dec 4, 2024 |
| Dec 2, 2024 | John A Allison director | AGrant or award 2023 Annual Restricted Stock Units | +20 | - | - | 2,484 | Dec 4, 2024 |
| Dec 2, 2024 | Joseph Simon Chief Financial Officer | AGrant or award 2020 Incentive RSUsderivative | +68 | $0.00 | $0 | 8,715 | Dec 4, 2024 |
| Dec 2, 2024 | Osamu R. Watanabe General Counsel, Secretary | AGrant or award 2020 Incentive RSUsderivative | +34 | $0.00 | $0 | 4,272 | Dec 4, 2024 |
| Dec 2, 2024 | Kenneth Shropshire director | AGrant or award 2024 Annual Restricted Stock Units | +16 | - | - | 2,064 | Dec 4, 2024 |
| Dec 2, 2024 | Laila Worrell director | AGrant or award 2024 Annual Restricted Stock Units | +15 | - | - | 1,970 | Dec 4, 2024 |
| Dec 2, 2024 | Ciafone Katherine Pilcher Chief Operating Officer | AGrant or award 2020 Incentive RSUsderivative | +22 | $0.00 | $0 | 2,843 | Dec 4, 2024 |
| Dec 3, 2024 | Eric Cantor Vice Chairman, MD | FTax withholding Class A Common Stock | -1,356 | $75.81 | $103k | 197,233 | Dec 4, 2024 |
| Dec 2, 2024 | John A Allison director | AGrant or award 2024 Annual Restricted Stock Units | +15 | - | - | 1,970 | Dec 4, 2024 |
| Dec 2, 2024 | Christopher Callesano Principal Accounting Officer | AGrant or award 2020 Incentive RSUsderivative | +7 | $0.00 | $0 | 853 | Dec 4, 2024 |
| Dec 2, 2024 | Ciafone Katherine Pilcher Chief Operating Officer | AGrant or award 2021 Incentive RSUsderivative | +32 | $0.00 | $0 | 4,050 | Dec 4, 2024 |
| Dec 2, 2024 | John A Allison director | AGrant or award 2024 Elective Restricted Stock Units | +6 | - | - | 809 | Dec 4, 2024 |
| Dec 2, 2024 | Laila Worrell director | AGrant or award 2024 Elective Restricted Stock Units | +6 | - | - | 809 | Dec 4, 2024 |
| Dec 2, 2024 | Eric Cantor Vice Chairman, MD | AGrant or award 2019 Incentive RSUs Granted in 2019 (Quarterly Awards)derivative | +7 | $0.00 | $0 | 876 | Dec 4, 2024 |
| Dec 2, 2024 | Kenneth Shropshire director | AGrant or award 2024 Elective Restricted Stock Units | +1 | - | - | 183 | Dec 4, 2024 |
| Dec 2, 2024 | Christopher Callesano Principal Accounting Officer | AGrant or award 2021 Incentive RSUsderivative | +9 | $0.00 | $0 | 1,106 | Dec 4, 2024 |
| Dec 2, 2024 | Osamu R. Watanabe General Counsel, Secretary | AGrant or award 2021 Incentive RSUsderivative | +47 | $0.00 | $0 | 6,044 | Dec 4, 2024 |
| Dec 2, 2024 | Christopher Callesano Principal Accounting Officer | AGrant or award 2022 Incentive RSUsderivative | +18 | $0.00 | $0 | 2,324 | Dec 4, 2024 |
| Dec 2, 2024 | Osamu R. Watanabe General Counsel, Secretary | AGrant or award 2022 Incentive RSUsderivative | +60 | $0.00 | $0 | 7,682 | Dec 4, 2024 |
| Dec 2, 2024 | Eric Cantor Vice Chairman, MD | AGrant or award 2019 Incentive RSUsderivative | +81 | $0.00 | $0 | 10,300 | Dec 4, 2024 |
| Dec 2, 2024 | Ciafone Katherine Pilcher Chief Operating Officer | AGrant or award 2022 Incentive RSUsderivative | +60 | $0.00 | $0 | 7,682 | Dec 4, 2024 |
| Dec 2, 2024 | Osamu R. Watanabe General Counsel, Secretary | AGrant or award 2023 Incentive RSUsderivative | +60 | $0.00 | $0 | 7,603 | Dec 4, 2024 |
| Dec 2, 2024 | Christopher Callesano Principal Accounting Officer | AGrant or award 2023 Incentive RSUsderivative | +16 | $0.00 | $0 | 1,996 | Dec 4, 2024 |
| Dec 2, 2024 | Eric Cantor Vice Chairman, MD | AGrant or award 2020 Incentive RSUsderivative | +112 | $0.00 | $0 | 14,210 | Dec 4, 2024 |
| Dec 2, 2024 | Eric Cantor Vice Chairman, MD | AGrant or award 2021 Incentive RSUsderivative | +158 | $0.00 | $0 | 20,099 | Dec 4, 2024 |
| Dec 2, 2024 | Eric Cantor Vice Chairman, MD | AGrant or award 2022 Incentive RSUsderivative | +264 | $0.00 | $0 | 33,609 | Dec 4, 2024 |
| Dec 2, 2024 | Eric Cantor Vice Chairman, MD | AGrant or award 2023 Incentive RSUsderivative | +254 | $0.00 | $0 | 32,318 | Dec 4, 2024 |
| Dec 3, 2024 | Eric Cantor Vice Chairman, MD | MOption exercise 2023 Incentive RSUsderivative | +1,356 | $0.00 | $0 | 30,962 | Dec 4, 2024 |
| Nov 7, 2024 | Christopher Callesano Principal Accounting Officer | SOpen-market sale Class A Common Stock | -885 | $80.00 | $71k | 0 | Nov 12, 2024 |
| Oct 24, 2024 | Eric Cantor Vice Chairman, MD | MOption exercise Class A Common Stock | +890 | - | - | 197,624 | Oct 25, 2024 |
| Oct 24, 2024 | Eric Cantor Vice Chairman, MD | FTax withholding Class A Common Stock | -391 | $68.24 | $27k | 197,233 | Oct 25, 2024 |
| Oct 24, 2024 | Eric Cantor Vice Chairman, MD | MOption exercise 2019 Incentive RSUs (September)derivative | -890 | $0.00 | $0 | 0 | Oct 25, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- John A Allisondirector
- Thorold Barkerdirector
- Christopher CallesanoChief Financial Officer
- Eric CantorVice Chairman, MD
- Navid MahmoodzadeganCo-President, MD
- Kenneth MoelisChairman, CEO
- Louise Mirrerdirector
- Ciafone Katherine PilcherChief Operating Officer
- Jeffrey RaichCo-President, MD
- Joseph SimonChief Financial Officer
- Kenneth Shropshiredirector
- Osamu R. WatanabeGeneral Counsel, Secretary
- Laila Worrelldirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.